Novartis to Buy Myricx Bio for Up to $1.5 Billion
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
The Source
TWSJ
Entertainment
From $200 Loans to $30,000 Birkins, a Pawnshop Chain Serves the K-Shaped Economy
TWSJ·1d ago·3 min read
Entertainment
Two Banks Agreed to Merge. They Can’t Agree on How to Make Chili.
TWSJ·1d ago·3 min read
Entertainment
Italy’s Eni Invests $225 Million in U.S. Startup EnergyX’s Chile Lithium Project
TWSJ·1d ago·3 min read
Entertainment
France’s Thales to Take Stake in Maritime Drone Maker Exail Ahead of Takeover
TWSJ·1d ago·3 min read
Related
On this beat
Entertainment
Xiaomi Civi Series Discontinued With No Next-Generation Model Planned, Claims Tipster
GADGETS 360·1d ago·3 min read
Entertainment
I’ve spent 20 years teaching people to communicate. Phone anxiety has never been worse.
BI·1d ago·3 min read
Entertainment
WLD Price Prediction: Dead Cat Bounce or Real Recovery? $0.44 Is the Line in the Sand
BN·1d ago·3 min read
Entertainment
Tourist spots across Europe hit by wildfires as Greece warns of toxic smoke
INDEPENDENT·1d ago·3 min read
